1. Home
  2. TK vs KALV Comparison

TK vs KALV Comparison

Compare TK & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$11.55

Market Cap

937.1M

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.95

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TK
KALV
Founded
1973
N/A
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
937.1M
1.0B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
TK
KALV
Price
$11.55
$26.95
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.60
AVG Volume (30 Days)
598.5K
2.8M
Earning Date
05-13-2026
07-09-2026
Dividend Yield
15.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$50,000,000.00
Revenue This Year
N/A
$185.42
Revenue Next Year
N/A
$59.23
P/E Ratio
$13.43
N/A
Revenue Growth
N/A
495.66
52 Week Low
$7.12
$9.83
52 Week High
$14.38
$26.98

Technical Indicators

Market Signals
Indicator
TK
KALV
Relative Strength Index (RSI) 36.56 75.23
Support Level $11.01 $14.22
Resistance Level $14.12 N/A
Average True Range (ATR) 0.44 0.05
MACD -0.19 -0.26
Stochastic Oscillator 10.10 87.04

Price Performance

Historical Comparison
TK
KALV

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: